Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

समान संसाधन

• Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy
  द्वारा: Papadaki, Chara, और अन्य
  प्रकाशित: (2020)
• MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer
  द्वारा: Papadaki, Chara, और अन्य
  प्रकाशित: (2021)
• Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy
  द्वारा: Rounis, Konstantinos, और अन्य
  प्रकाशित: (2021)
• MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer
  द्वारा: Thomopoulou, Konstantina, और अन्य
  प्रकाशित: (2021)
• Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
  द्वारा: Papadaki, Chara, और अन्य
  प्रकाशित: (2019)